Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20003 ↗At a glance
Journal article in British Journal of Haematology, 2025. Written by Rithin Nedumannil and 5 co-authors. Institution: Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. Major MEDLINE topics: Janus Kinase 2, Primary Myelofibrosis, Hematopoietic Stem Cell Transplantation. Cited 3 times so far (Crossref); 10 references. Funded by: The Wilson Centre for Blood Cancer Genomics, Snowdome Foundation.
Abstract (original language)
Relapse after allogeneic stem cell transplantation (alloSCT) represents a frequent complication in patients with myelofibrosis (MF). This retrospective study analysed 38 patients with JAK2 ‐mutated MF who underwent alloSCT. Serial sensitive molecular assessments at regular intervals of JAK2 V617F revealed that a ≥2‐fold increase in JAK2 variant allele frequency (VAF) at days +100 and +180 post‐alloSCT was highly predictive of eventual morphological relapse. The integration of JAK2 VAF monitoring with chimerism analysis into post‐alloSCT care represents a novel strategy for early detection of MF relapse, which may enable timely interventions and improve outcomes in such high‐risk patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
ORCID profiles: Rithin Nedumannil, Piers Blombery, Jeff Szer, David S Ritchie
Funding
- The Wilson Centre for Blood Cancer Genomics
- Snowdome Foundation
Cite
APA
Nedumannil, R., Karmi, T., Blombery, P., Szer, J., Ritchie, D. S., & Chee, L. C. Y. (2025). Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis. British Journal of Haematology. https://doi.org/10.1111/bjh.20003
Vancouver
Nedumannil R, Karmi T, Blombery P, Szer J, Ritchie DS, Chee LCY. Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis. British Journal of Haematology. 2025. doi:10.1111/bjh.20003
BibTeX
@article{Nedumannil2025,
author = {Nedumannil, Rithin and Karmi, Tal and Blombery, Piers and Szer, Jeff and Ritchie, David S and Chee, Lynette C Y},
title = {Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20003}
}
EUVIMED